SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cosmos Health Inc. – ‘8-K’ for 4/13/23

On:  Tuesday, 4/18/23, at 8:35am ET   ·   For:  4/13/23   ·   Accession #:  1477932-23-2688   ·   File #:  1-41308

Previous ‘8-K’:  ‘8-K’ on 3/6/23 for 2/28/23   ·   Next:  ‘8-K’ on 5/11/23 for 5/8/23   ·   Latest:  ‘8-K/A’ on 5/3/24 for 4/26/24   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/18/23  Cosmos Health Inc.                8-K:2,9     4/13/23   13:216K                                   Discount Edgar/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     23K 
 2: EX-99.1     Press Release                                       HTML     57K 
 8: R1          Cover                                               HTML     47K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 9: XML         XBRL Instance -- cosm_8k_htm                         XML     15K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 5: EX-101.CAL  XBRL Calculations -- cosm-20230413_cal               XML      8K 
 7: EX-101.DEF  XBRL Definitions -- cosm-20230413_def                XML     11K 
 4: EX-101.LAB  XBRL Labels -- cosm-20230413_lab                     XML     45K 
 6: EX-101.PRE  XBRL Presentations -- cosm-20230413_pre              XML     30K 
 3: EX-101.SCH  XBRL Schema -- cosm-20230413                         XSD     19K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
13: ZIP         XBRL Zipped Folder -- 0001477932-23-002688-xbrl      Zip     22K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C: 
 i 0001474167 i false00014741672023-04-132023-04-13iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM  i 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)  i April 13, 2023

 

 i Cosmos Health Inc.

(Exact name of registrant as specified in its charter)

 

 i Nevada

 

 i 000-54436

 

 i 27-0611758

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

 i 141 West Jackson Blvd,  i Suite 4236,

 i Chicago,  i Illinois

 

 i 60604

(Address of principal executive offices) 

 

(Zip Code)

 

Registrant’s telephone number, including area code ( i 312)  i 865-0026

 

N/A

(Former name or former address, if changed since last report.)

 

Title of Each Class

 

Trading

Symbol

 

Name of Each Exchange

On Which Registered

 i Common Stock, $.001 par value

 

 i COSM

 

 i Nasdaq Capital Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 i 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 i 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 i 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 i 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).

 

Emerging growth company  i 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITIONS

 

A copy of the Company’s press release dated April 13, 2023 titled: “Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022” is filed as Exhibit 99.1 to this Current Report on Form 8-K.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(d) Exhibits 

 

Number

 

 

 

99.1

Press Release dated April 13, 2023 titled: “Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022.”

104

Cover Page Interactive Data File (embedded within the Inline XBRL Document)

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

COSMOS HEALTH INC.

 

Date: April 18, 2023

By:

/s/ Georgios Terzis

Georgios Terzis

 

Chief Financial Officer

 

 

 

3

 


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on:4/18/23None on these Dates
For Period end:4/13/23
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/29/24  Cosmos Health Inc.                424B3                  1:333K                                   Discount Edgar/FA
 2/15/24  Cosmos Health Inc.                424B3                  1:163K                                   Discount Edgar/FA
 1/29/24  Cosmos Health Inc.                S-3                    4:460K                                   Discount Edgar/FA
 8/31/23  Cosmos Health Inc.                424B3                  1:185K                                   Discount Edgar/FA
 8/18/23  Cosmos Health Inc.                S-3                    4:521K                                   Discount Edgar/FA
 7/21/23  Cosmos Health Inc.                424B5                  1:404K                                   Discount Edgar/FA
Top
Filing Submission 0001477932-23-002688   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 2:07:28.1pm ET